Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
about
Protein secretion in Lactococcus lactis : an efficient way to increase the overall heterologous protein productionDisplay of recombinant proteins at the surface of lactic acid bacteria: strategies and applicationsHigh-throughput system for the presentation of secreted and surface-exposed proteins from Gram-positive bacteria in functional metagenomics studiesExtracellular expression of a functional recombinant Ganoderma lucidium immunomodulatory protein by Bacillus subtilis and Lactococcus lactisHeterologous production of human papillomavirus type-16 L1 protein by a lactic acid bacteriumPerspectives for preventive and therapeutic HPV vaccines.Extracellular secretion of anticoagulant peptide hirudin in Lactococcus lactis using SP310mut2 signal peptide.Immunotherapy for cervical cancer: Research status and clinical potentialProduction and targeting of the Brucella abortus antigen L7/L12 in Lactococcus lactis: a first step towards food-grade live vaccines against brucellosisProduction of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.Lactic acid bacteria--20 years exploring their potential as live vectors for mucosal vaccination.Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines.Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice.The secreted L-arabinose isomerase displays anti-hyperglycemic effects in miceSecretion of biologically active interferon-gamma inducible protein-10 (IP-10) by Lactococcus lactis.Nisin inducible production of listeriolysin O in Lactococcus lactis NZ9000Influence of lipoteichoic acid D-alanylation on protein secretion in Lactococcus lactis as revealed by random mutagenesis.Current prophylactic and therapeutic uses of a recombinant Lactococcus lactis strain secreting biologically active interleukin-12.Characterization of a Lactococcus lactis strain that secretes a major epitope of bovine beta-lactoglobulin and evaluation of its immunogenicity in miceOral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis.Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development.Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells.Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts.Controlled production of stable heterologous proteins in Lactococcus lactisA plasmid selection system in Lactococcus lactis and its use for gene expression in L. lactis and human kidney fibroblasts.Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.New expression system tightly controlled by zinc availability in Lactococcus lactis.Recombinant Lactococcus lactis Expressing Haemagglutinin from a Polish Avian H5N1 Isolate and Its Immunological Effect in Preliminary Animal Trials.Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines.A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.Engineering the cell surface display of cohesins for assembly of cellulosome-inspired enzyme complexes on Lactococcus lactis.Factors Affecting Inducible Expression of Outer Membrane Protein A (OmpA) of Shigella dysenteriae Type-1 in Lactococcus lactis Using Nisin Inducible Controlled Expression (NICE).Immunopathological evaluation of recombinant mycobacterial antigen Hsp65 expressed in Lactococcus lactis as a novel vaccine candidate.Secretion of Streptomyces tendae antifungal protein 1 by Lactococcus lactis.Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy.Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks the neutrophil extracellular traps and is needed for full virulence.Antimicrobial activity of divercin RV41 produced and secreted by Lactococcus lactis.Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surfaceTherapeutic human papillomavirus vaccines: current clinical trials and future directions
P2860
Q24808692-83A7603C-7C58-4F35-9B4F-B82E12526ED1Q26753101-F85376E0-8235-492C-BE3C-6AFBF02C5BA0Q28533942-68C05614-40DA-4C9F-A455-DE9D8935BEF8Q33312172-07F61478-C813-4895-A5D4-2A3C23F3DDBEQ33496351-16DF8B76-88CB-40AB-89B4-524758C2D840Q34011494-F01D6138-5045-4259-8D60-A0EB3CB11BF6Q34013880-66256C16-C55D-43D1-B541-EEDC7F97D05DQ34033763-F12DB6AD-7E54-4E83-9617-47BEA16803E8Q34099800-971FC94B-F9CA-46FD-A303-52A802363422Q34315981-F69E972B-7910-42F4-BF8A-54206CE7C92BQ35193105-1E3D62CE-C507-4CCE-B4FF-820E3A225AA8Q35596025-19611635-23B2-471E-B49A-D021077DDEA4Q35946659-9730936B-C345-4D50-8515-59C0A48EDA3FQ36393273-F09B3FCA-6207-4CC7-88A7-945AD6226A3AQ36823286-2316CA4B-6955-49C0-93C7-DCF46E1AA1A5Q36835482-425A5AE5-F978-4CF4-A046-4F01010F03FAQ36929786-B7B8D573-6B80-4E0C-B7C1-3B15FBE79016Q36980257-48C7D36A-5DF0-436E-B3AC-6CFB263E333FQ37054925-4357C152-8474-4989-8E4B-ECCEC8C59013Q37545006-DBFDBFF8-1BD4-46D3-8ABF-B039EA45424FQ37640672-50049E46-F7D2-4A61-AAA6-56395DA4D456Q38221560-0449BE1A-A003-46C1-A4A7-0E687D615F33Q39108993-7D76DF99-856E-4184-9A64-648F3A91B990Q39179768-9F82AF9D-6E3C-4D59-B8AC-29931E8F479CQ39639833-9069CFBD-3B86-45CB-82ED-504B91CBBBA3Q39648844-43A1737C-1937-4472-B805-859150D363FCQ39741884-0E3D54B8-92BE-411C-A742-B023E7027F6DQ40129313-90E48DD6-ABA0-4F3D-87AD-691C5161F089Q40283850-7A45D78A-2381-4566-B4C3-A5E23C485058Q40409120-BBE79720-74F8-446E-8CC6-93C02F37312EQ41839546-1BADB0BF-478E-4700-9EE1-6B36E17348B6Q42414145-EA8A9414-9491-474D-98C9-7D11023C68C2Q43065364-CCD21D47-2C4D-4BC6-AFE4-5B44EA8FA331Q46762252-F03026FE-8C78-4EB5-A352-1DF8A233275AQ46782291-5B2FE5EF-F2DF-4107-B83C-FFEFB2C88651Q49444745-3D30374D-38A0-49AF-AC3F-62F9D3ED3938Q50902280-C782A7E8-7757-4737-8096-BAF20916B3D1Q54434673-10775B35-7692-4F93-B3D2-0CCFFCC1AB54Q56891832-1C878EDA-45B8-4151-948F-E113F3DB4828Q56937332-F7550358-4B62-43EB-9DC7-CD93CB28BF5D
P2860
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@ast
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@en
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@nl
type
label
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@ast
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@en
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@nl
prefLabel
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@ast
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@en
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@nl
P2093
P2860
P1476
Production of human papillomavirus type 16 E7 protein in Lactococcus lactis.
@en
P2093
L G Bermúdez-Humarán
P Langella
R Tamez Guerra
Roberto Montes de Oca-Luna
Yves Le Loir
P2860
P304
P356
10.1128/AEM.68.2.917-922.2002
P407
P577
2002-02-01T00:00:00Z